Global cognitive level and antidepressant efficacy in post-stroke depression

Author： Spalletta Gianfranco   Caltagirone Carlo  

Publisher： Springer Publishing Company

ISSN： 0033-3158

Source： Psychopharmacology, Vol.175, Iss.2, 2004-09, pp. : 262-263

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Therapy for prevention of post-stroke depression

By Ramasubbu Rajamannar  

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 14, 2011-10 ,pp. : 2177-2187

Informa Healthcare

Access to resources Recommend Favorite

Oxidative Stress and Post-Stroke Depression: Possible Therapeutic Role of Polyphenols?

By  

Current Medicinal Chemistry, Vol. 22, Iss. 3, 2015-01 ,pp. : 343-351

Bentham Science Publishers

Access to resources Recommend Favorite

The Clinical Neuroscience of Post Stroke Depression

By  

Current Neuropharmacology, Vol. 2, Iss. 4, 2004-10 ,pp. : 353-362

Bentham Science Publishers

Access to resources Recommend Favorite

Prediction of the response to citalopram and reboxetine in post-stroke depressed patients: the reasons of the enrollment of patients without cognitive impairment

By Rampello Liborio   Alvano Alessandro  

Psychopharmacology, Vol. 175, Iss. 2, 2004-09 ,pp. : 264-264

Springer Publishing Company

Access to resources Recommend Favorite

Minocycline may improve post-stroke outcomes

By  

Inpharma, Vol. 1, Iss. 1616, 2007-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite